President & CEOOfficers of the CorporationBoard of TrusteesFoundation BoardLeadership CouncilAbout Joslin ResearchAdvocacy & Gov't AffairsHistory
Newly DiagnosedManaging DiabetesChildhood DiabetesNutritionExerciseOnline Diabetes ClassesDiscussion BoardsJoslin Clinical ResearchInfo for Healthcare ProfessionalsJoslin Clinical Guidelines
Make an AppointmentAdult ClinicYoung Adult Transition CarePediatricsEye CareWeight Management ProgramsDO ITMental Health & CounselingReferring PhysiciansBillingAfrican American ProgramsAsian ClinicLatino Diabetes InitiativeAbout Joslin ResearchVolunteer for Clinical Research StudiesInfo for Healthcare ProfessionalsClinical Guidelines
Directory of Joslin InvestigatorsDiabetes Research Center Alumni ConnectionVolunteer for Clinical Research Studies
Media RelationsNews ReleasesInside Joslin
Affiliated CentersPharma & DeviceCorporate EducationPublicationsProfessional EducationInternationalCause MarketingHealthcare ProfessionalsCommercialization and VenturesJoslin Institute for Technology Translation (JITT)
Give NowHigh Hopes FundWays to GivePlanned GivingEventsGet InvolvedCorporate & Foundation SupportOur DonorsDevelopment Team

Primary Care Congress for Cardiometabolic Health 2013

View and download the Brochure.


Mission

The overall goal of the Primary Care Congress for Cardiometabolic Health is to improve knowledge, skills, clinical care, and outcomes at the primary level, inclusive of timely and efficient interaction and communication with specialists such as cardiologists, endocrinologists, and nephrologists, among others.

The cardiometabolic syndrome is a construct of risk factors that increase the risk of developing cardiovascular disease. While there is some debate as to whether this is truly a syndrome with interconnecting pathophysiologic roots, the clinical implications are clear and are becoming increasingly crucial for clinicians to understand. These risk factors must be addressed early and effectively, because their clinical associations with an expanding array of other important medical conditions are significant to both the health of many individuals and our ability to address the national and international epidemic of the resulting cardiovascular disease.

This program will therefore examine at a high level the components of the cardiometabolic syndrome, its related clinical conditions, and clinical approaches to control them. It will include discussions of cutting-edge basic and clinical science that build upon the latest data and evidence-based clinical care recommendations, and then emphasize practical applications through discussion of care parameters and actual cases to illustrate these key points. The goal is for learners to appreciate the spectrum of clinical implications and patient presentations that this constellation of syndrome-like abnormalities can bring with it, and to improve their clinical skills by addressing these abnormalities in a timely and effective manner.


Course Directore & Advisors

Course Directors

Martin J. Abrahamson, MD
Associate Professor of Medicine
Harvard Medical School
Medical Director
Joslin Diabetes Center
Richard S. Beaser, MD
Associate Clinical Professor of Medicine
Harvard Medical School
Medical Executive Director
Professional Education
Joslin Diabetes Center
Donald E. Cutlip, MD
Associate Professor of Medicine
Harvard Medical School
Director, Cardiac Catheterization Laboratory
Beth Israel Deaconess Medical Center
Ruth Hertzman-Miller, MD, MPH
Director of Medical Programs
Professional Education
Joslin Diabetes Center
Eleftheria Maratos-Flier, MD
Professor of Medicine
Harvard Medical School
Physician
Beth Israel Deaconess Medical Center

National Cardiometabolic Expert Group

Deepak L. Bhatt, MD, MPH
Harvard Medical School
VA Boston Healthcare System
Brigham and Women's Hospital

Lawrence Blonde, MD, FACP, FACE
Ochsner Health System Diabetes Clinical
  Research Unit

Samuel Dagogo-Jack, MD, FRCP, FACP, FACE
University of Tennessee Health
  Science Center

Fredrick Dunn, MD
University of Texas Southwestern
  Medical Center

Vivian Fonseca, MD
Tulane University Health Sciences Center

Joanne Foody, MD
Brigham and Women's Hospital

James Gavin III, MD, PhD
Emory University School of Medicine
Healing Our Village, Inc.

Andre T. Guay, MD, FACP, FACE
Tufts University School of Medicine
Lahey Clinic Northshore
Yehuda Handelsman MD, FACP, FACE, FNLA
Metabolic Institute of America
Chair, ICIR

Irl Hirsch, MD
University of Washington

Paul Jellinger, MD
University of Miami
Past President, ACE, AACE

Etie Moghissi, MD, FACP, FACE
University of California, Los Angeles

Richard Pratley, MD
Florida Hospital Diabetes Mellitus Institute

Paul Ridker, MD, MPH
Brigham and Women's Hospital

Michael Rocco, MD
Cleveland Clinic

Julio Rosenstock, MD
Dallas Diabetes and Endocrine Center at Medical City
University of Texas Southwestern Medical Center

Dace Trence, MD
University of Washington Medical Center

Faculty Advisors

Enrique Caballero, MD
Harvard Medical School
Joslin Diabetes Center

Sanjiv Chopra, MBBS, MACP
Harvard Medical School
Beth Israel Deaconess Medical Center

Donald E. Cutlip, MD
Harvard Medical School
Beth Israel Deaconess Medical Center

Osama Hamdy, MD, PhD, FACE
Harvard Medical School
Joslin Diabetes Center

Edward S. Horton, MD
Harvard Medical School
Joslin Diabetes Center

C. Ronald Kahn, MD
Harvard Medical School
Joslin Diabetes Center
JoAnn E. Manson, MD, DrPh
Harvard Medical School
Brigham and Women's Hospital

David M. Nathan, MD
Harvard Medical School
Massachusetts General Hospital

Jorge Plutzky, MD, FACC
Harvard Medical School
Brigham and Women's Hospital

Robert C. Stanton, MD
Harvard Medical School
Joslin Diabetes Center

Robert Thomas, MD
Harvard Medical School
Beth Israel Deaconess Medical Center


Agenda

Day 1: Tuesday, April 23, 2013

7:00
AM
Registration and Breakfast

8:00
Welcome and Introduction

8:10
Pathophysiology of Type 2 Diabetes
C. Ronald Kahn, MD

8:50
Inflammation in Coronary Artery Disease and the Etiology of the Cardiovascular Lesion
Jorge Plutzky, MD, FACC

9:30
The Metabolic Syndrome: Is It a Valid Concept? Point Counterpoint
Edward S. Horton, MD, Richard Kahn, MD

10:10
Break

10:25
The GI Tract in the Etiology of the Cardiometabolic Syndrome
Suzanne Devkota, MD

11:10
NEW ADDITION!!
Cardiometabolic Health Clinical Trial and FDA Update

12:00
PM
Lunch

12:40
Epidemiology of Diabetes and Cardiovascular Disease in Special Populations
Enrique Caballero, MD, William C. Hsu, MD, Eyiuche Okeke, MD

1:20
New and Evolving Treatments for Type 2 Diabetes: Looking to the Horizon
Martin J. Abrahamson, MD

2:00
New Insulins: The 1921 Discovery Keeps on Evolving
Richard S. Beaser, MD

2:40
Break

2:55
New Perspectives on the Pathogenesis of Obesity
Eleftheria Maratos-Flier, MD

3:45
Nutrition and Treatment for Cardiometabolic Risk: The Science and the Applications
David Eisenberg, MD

4:35
Long-Term Weight Management in Obese Patients With Diabetes
Osama Hamdy, MD, PhD, FACE

5:10
Panel Discussion and Questions on Case Vignette
PM Faculty

5:40
Break

6:30
Introduction to Evening Session and Case Vignette: A Patient with Obesity and Type 2 Diabetes
Osama Hamdy, MD, PhD, FACE

6:40
Effective Lifestyle Intervention That Finally Works
Edward Phillips, MD

7:10
Pharmacotherapy of Obesity: To Use or Not to Use?
Jody Dushay, MD, MMSe

7:40
Surgical Treatments for Obesity: Cutting to the Solution
Robert Andrews, MD, FACS

8:10
Nonsurgical vs Surgical: Table Debates
Osama Hamdy, MD, PhD, FACE

8:25
Express Debate of the Case
All faculty plus RD, Exercise Physiologist

9:00
Adjournment

Day 2: Wednesday, April 24, 2013

7:00
AM
Registration and Breakfast

8:00
Introduction to Day 2

8:10
Nonalcoholic Fatty Liver Disease
Sanjiv Chopra, MBBS, MACP

8:50
Chronic Kidney Disease and Cardiovascular Risk: Interrelationships and Interventions
Robert Stanton, MD

9:30
Dental and Cardiovascular Diseases: Are They Intertwined?
William C. Hsu, MD

10:10
Break

10:25
Coronary Artery Disease in Women: Clinical perspectives
JoAnn Manson, MD, DrPH

11:05
Modifying Atherosclerosis in Cardiometabolic Disease: Targeting Inflammation?
Peter Libby, MD

11:35
PM
Lunch

12:25
Obesity, Fat, and Metabolism
Aaron Cypess, MD, PhD, MMSc

1:10
Prevention Lessons from the DPP: Real-World Applications
David Nathan, MD

2:00
Cardiometabolic Syndrome and Biological, Social, and Cultural Variability: Clinical Perspectives
Enrique Caballero, MD

2:45
Break

3:10
Treating Hypertension in the Context of Cardiometabolic Risk
Mark Williams, MD, FACE, FASN

3:40
Treating Dyslipidemia: An Evolving Paradigm
Om Ganda, MD

4:10
New Approaches to, and Indications, for Antiplatelet Therapy
Kenneth Bauer, MD

4:40
Panel Discussion
PM Faculty

5:20
Break

6:30
Cardiometabolic Disease in Racial and Ethnic Minorities: Introduction
Enrique Caballero, MD

6:40
Healthcare Disparities in Cardiometabolic Risk
Gary Puckrein, PhD

7:10
Approaches to Reduce Cardiovascular Risk in Minorities
Keith Ferdinand, MD, FACC, FAHA

7:40
Community-Based Interventions to Reduce CV Risk in Vulnerable Populations
Enrique Caballero, MD

8:10
Panel Discussion: Effective Strategies to Eliminate Healthcare Disparities in Cardiometabolic Disease
All Faculty

8:45
Q&A
All Faculty

9:00
Adjournment

Day 3: Thursday, April 25, 2013

7:00
AM
Breakfast

8:10
Acute Coronary Syndromes: Prevention, Diagnosis, and Treatment
Julian Aroesty, MD

8:50
Chronic Coronary Artery Disease Management
Donald Cutlip, MD

9:30
Minimally Invasive Treatments for Vascular Disease: The Era of the Stent
Duane Pinto, MD, MPH, FACC

10:10
Refreshment Break

10:25
Panel Discussion: Cardiometabolic Syndrome and CA
AM Faculty

10:50
Interactive Case
Sleep Apnea: Its Impact on Cardiovascular Disease

Robert Thomas, MD

11:40
Androgen Deficiency and Coronary Artery Disease: Is There a Link?
Martin Miner, MD

12:20
PM
Closing Remarks and Adjournment
Moderators


CME Information


Learning Objectives
As a result of this education, attendees will acquire an improved understanding of the pathophysiology of the cardiometabolic syndrome and its related conditions, and will be updated on recent advances in the treatment of these conditions in the context of their etiology and clinical interconnections. The interactive teaching and case vignette discussions will emphasize clinical skills improvements, particularly in the context of specific patient populations and special situations that present clinical challenges in the management of this constellation of conditions.

Upon completion of this activity, participants will be able to:

  • Identify markers that identify increased cardiometabolic risk, including components of cardiometabolic syndrome, biomarkers, and other key clinical factors
  • Describe therapeutic goals for the treatment of key cardiometabolic risk factors
  • Demonstrate the ability to screen for cardiometabolic risk, and when present, develop programs to treat them to recommended targets
  • Describe the role of obesity in the etiology of cardiometabolic risk, and methods to manage weight so as to reduce that risk
  • Discuss the clinical presentation of, and potential treatments for, cardiovascular disease in people with type 2 diabetes and/or the cardiometabolic syndrome
  • Identify the main biological, social, and cultural factors that influence the development of the cardiometabolic syndrome among racial and ethnic minorities as well as effective preventive and treatment strategies to improve their clinical care
  • Describe medical conditions that are related to or associated with the cardiometabolic syndrome, how they are diagnosed, and treatment options
  • Describe methods to self-assess one’s own practice to determine what cardiometabolic risk factor interventions will be provided within the practice vs what will be outsourced to area specialty resources and how that care will be coordinated
  • Utilize the Joslin Professional Education Continuum (JPEC) Cardiometabolic risk stratification and reduction clinical center to obtain additional support materials as well as participate in ABIM MOC qualified performance improvement CME activities


Who Should Attend?
This activity is designed to improve knowledge, competence and performance at the primary level, where most care takes place, as well as to improve coordination and communication with specialists and the delivery of specialty care.

Those interested in attending should be clinicians who provide primary care either as family practitioners or internists (MD, DO, NP, PA), as well as internal medicine specialists, who are self-identified as having significant numbers of patients who have or are at risk for developing the cardiometabolic syndrome of risk factors, and/or the end-organ results of their metabolic impact, or those with an interest in this area, such as:

  • General Practitioners (MD, DO, PA, NP)
  • Internists
  • Family Practitioners
  • Cardiologists
  • Nephrologists
  • Endocrinologists
  • Allied Health (RN, CDE, Pharmacists)
  • Relevant industry professionals, advocacy groups, and consultants


Accreditation and Designation of Credit
The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Harvard Medical School designates this live activity for a maximum of 25 AMA PRA Category 1 Credits.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For CEU credits for allied health professionals, please submit a copy of your certificate, along with the program agenda and learning objectives, to your state licensing board at the conclusion of the course for credits.


ACGME Competencies
This activity is designed to meet one or more of the following Accreditation Council of Graduate Medical Education competencies:

  • Patient care
  • Medical knowledge
  • Professionalism

Disclosure Policy
Harvard Medical School (HMS) adheres to all ACCME Essential Areas, Standards, and Policies. It is HMS’s policy that those who have influenced the content of a CME activity (e.g., planners, faculty, authors, reviewers, and others) disclose all relevant financial relationships with commercial entities so that HMS may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.


Faculty*

Martin J. Abrahamson, MD
Associate Professor of Medicine
Harvard Medical School
Medical Director
  and Senior Vice President
Joslin Diabetes Center

Robert A. Andrews, MD, FACS
Division of General Surgery
Section of Minimally Invasive
  Surgery and Bariatrics Instructor, Surgery
Harvard Medical School
Department of Surgery
Beth Israel Deaconess Medical Center

Julian M. Aroesty, MD
Associate Clinical Professor of Medicine
Harvard Medical School
Staff Physician, Cardiology
Beth Israel Deaconess Medical Center

Kenneth A. Bauer, MD
Professor of Medicine
Harvard Medical School
Chief, Hematology Section
VA Boston Healthcare System
Director, Thrombosis Clinical Research
Beth Israel Deaconess Medical Center

Richard S. Beaser, MD
Associate Clinical Professor
  of Medicine
Harvard Medical School
Medical Executive Director
Professional Education
Joslin Diabetes Center

Enrique Caballero, MD
Assistant Professor of Medicine
Harvard Medical School
Director, Medical Affairs
Professional Education
Director, Latino Diabetes Initiative
Joslin Diabetes Center

Sanjiv Chopra, MBBS, MACP
Professor of Medicine
Faculty Dean for Continuing Education
Harvard Medical School
Senior Consultant in Hepatology
Beth Israel Deaconess Medical Center

Donald E. Cutlip, MD
Associate Professor of Medicine
Harvard Medical School
Executive Director Clinical Trials
Harvard Clinical Research Institute
Director, Cardiac Catheterization
  Laboratory
Beth Israel Deaconess Medical Center

Aaron M. Cypess, MD, PhD, MMSc
Assistant Professor
Harvard Medical School
Assistant Investigator
  and Staff Physician
Joslin Diabetes Center

Suzanne Devkota, PhD
Research Fellow
Joslin Diabetes Center
Jody Dushay, MD, MMSc
Instructor in Medicine
Harvard Medical School
Division of Endocrinology
Beth Israel Deaconess Medical Center

David M. Eisenberg, MD
Bernard Osher Associate Professor of Medicine
Director of Osher Institute
Division for Research and Education
in Complementary and Integrative Medical Therapies
Harvard Medical School
Director of Osher Integrative Care Center and Program
in Integrative Medicine
Brigham and Women’s Hospital

Sukran Ergin, MD
Instructor in Medicine
Harvard Medical School
Physician, Division of Rheumatology
Beth Israel Deaconess Medical Center

Keith C. Ferdinand, MD, FACC, FAHA
Professor of Clinical Medicine
Tulane University School of Medicine

Om P. Ganda, MD
Associate Clinical Professor
  of Medicine
Harvard Medical School
Director
Lipid Clinic
Joslin Diabetes Center

Osama Hamdy, MD, PhD, FACE
Assistant Professor of Medicine
Harvard Medical School
Medical Director
Obesity Clinical Program
Joslin Diabetes Center

Edward S. Horton, MD
Professor of Medicine
Harvard Medical School
Senior Investigator
Joslin Diabetes Center

William C. Hsu, MD
Assistant Professor of Medicine
Harvard Medical School
Director, Asian Clinic
Joslin Diabetes Center

C. Ronald Kahn, MD
Mary K. Iacocca Professor
Harvard Medical School
Joslin Diabetes Center

Richard Kahn, PhD
Chief Scientific and Medical Officer
American Diabetes Association

Peter Libby, MD
Chief, Division of Cardiovascular
   Medicine
Brigham and Women’s Hospital

JoAnn E. Manson, MD, DrPh
Professor of Medicine
Michael and Lee Bell Professor
  of Women’s Health
Harvard Medical School
Chief, Division of Preventive Medicine
Brigham and Women’s Hospital
Martin Miner, MD
Clinical Associate Professor of Family Medicine and Urology
Warren Alpert School of Medicine
Brown University
Co-Director, Men’s Health Center
Chief of Family and Community Medicine
Miriam Hospital

Eleftheria Maratos-Flier, MD
Professor of Medicine
Harvard Medical School
Physician
Beth Israel Deaconess Medical Center

David M. Nathan, MD
Professor of Medicine
Harvard Medical School
Director, Diabetes Center and Clinical
  Research Center
Massachusetts General Hospital

Eyiuche Okeke, MD
Instructor in Medicine
Harvard Medical School
Outcomes Investigator
Professional Education
Staff Endocrinologist
Joslin Diabetes Center

Edward M. Phillips, MD
Assistant Professor of Physical Medicine
  and Rehabilitation
Harvard Medical School
Director, Outpatient Medical Services
Spaulding Rehabilitation Hospital Network

Duane S. Pinto, MD, MPH, FACC
Associate Professor of Medicine
Harvard Medical School
Director, Cardiac Intensive Care Unit
Associate Director, Interventional
  Cardiology Section
Beth Israel Deaconess Medical Center

Jorge Plutzky, MD, FACC
Associate Professor of Medicine
Harvard Medical School
Director, The Vascular Disease
  Prevention Program
Brigham and Women’s Hospital

Gary Puckrein, PhD
President
National Minority Quality Forum
Washington, DC

Robert C. Stanton, MD
Associate Professor of Medicine
Harvard Medical School
Chief of Nephrology
Joslin Diabetes Center

Robert Thomas, MD
Assistant Professor of Medicine
Harvard Medical School
Physician and Assistant Professor
Pulmonary, Critical Care & Sleep, Department of Medicine
Beth Israel Deaconess Medical Center

Mark E. Williams, MD, FACP, FASN
Associate Professor of Medicine
Harvard Medical School
Co-Director of Dialysis
Beth Israel Deaconess Medical Center
Senior Staff Physician
Joslin Diabetes Center

*Subject to change


Registration

Attendance is limited—register early and save up to $600!


Registration 

Registration with Promo Code


Registration by check can be made by downloading the Registration Form and mailing it, with a check (draft on a United States bank) made payable to Harvard Medical School, to Harvard Medical School–Department of Continuing Education, PO Box 417476, Boston, MA 02241-7476. Telephone or fax registration is not accepted. Registration with cash payment is not permitted. Upon receipt of your paid registration an email confirmation will be sent to you from the HMS-DCE office. Be sure to include an email address that you check frequently.




Accommodations/Travel
A limited number of rooms have been reserved at the Seaport Hotel (Telephone: 1-800-440-3318) until March 29, 2013. Please specify that you are enrolled in this course to receive a reduced room rate of $249 per night for Single and Double Rooms.

Please do not purchase nonrefundable airline ticket(s) until you have received an email from our office confirming your paid registration. For airline reservations contact the HMS Travel Desk toll-free 1-877-4-HARVMD (1-877-442-7863) Monday–Friday 9–8 (ET). From outside the U.S., Canada, and Virgin Islands, please call 617-559-3764.

In compliance with the Americans with Disabilities Act, Harvard Medical School will make every reasonable effort to accommodate your needs during your attendance at this activity. For any special requests, please contact Joslin Diabetes Center at 888-567-5460.

This activity has been submitted for independent commercial grant support. No support had been awarded when this brochure went to press.


Refund Policy
A handling fee of $60 is deducted for cancellation. Refund requests must be received by postal mail, email, or fax one week prior to this activity. No refunds will be made thereafter.


Inquiries
By phone 617-384-8600, MondayÐFriday, 10Ð4 (ET) or by email at hms-cme@hms.harvard.edu


Supporters & Strategic Partners*


Page last updated: August 02, 2014